Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp
Bullboard Posts
User Avatar Image
(49)
•••
Comment by Righttothetopon Mar 27, 2020 10:06am
131 Views
Post# 30852553

RE:RE:RE:RE:RE:RE:RE:RE:RE:Seriously...WTF

RE:RE:RE:RE:RE:RE:RE:RE:RE:Seriously...WTF
KohKut wrote:
stealthct wrote:
KohKut wrote:
lscfa wrote: To nitpick it was $7.7 for Q4. There was some non-payment in Q1 too....

jan 30 - As at December 31, 2019, the Company’s unaudited past due balance was approximately $8.6 million, of which $7.7 million was related to the statement of claim.



seajust wrote: you know if it is the late friday after noon news release we are screwed. I am hoping for a Friday morn with some good news, the $9 mil charge against HEXO is my most pressing issue, it depends where there throw it in the mix.  

 


LABS will be fine,just a good shake before earnings as people are trading the swings these dayz......IMHO sp rises before close as investors get set for next week.
 



7.7M is nothing. I'm sure HEXO wants to be in good standing with other companies, they wiill pay or have already paid it.


Agreed and there are means of collecting thru the proper authorities......or mutually agreed settelements. Market sell-off today,what did anyone expect after a couple good runs where 15% plus gains were witnessed on most traded exchanges. Investors setting up for next week.



Haha...I'm selfish and greedy!  I want a market cap of $1bil like other semi/kind-of/maybe profitable other outfits in the space....given LABS is wickedly so and only getting better!  :)
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities